Holen Sie sich die Stockscreener-App
0.1878
1.16%
-0.0022
Handel nachbörslich:
.30
0.1122
+59.74%
Schlusskurs vom Vortag:
$0.19
Offen:
$0.1875
24-Stunden-Volumen:
496.78K
Relative Volume:
0.13
Marktkapitalisierung:
$8.43M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-9.88M
KGV:
-0.5154
EPS:
-0.3644
Netto-Cashflow:
$-9.98M
1W Leistung:
+1.51%
1M Leistung:
-12.69%
6M Leistung:
-82.11%
1J Leistung:
-97.02%
1-Tages-Spanne:
$0.185
$0.1902
1-Wochen-Bereich:
$0.1763
$0.192
52-Wochen-Spanne:
$0.1592
$33.66
Liminatus Pharma Inc Stock (LIMN) Company Profile
Firmenname
Liminatus Pharma Inc
Sektor
Branche
Telefon
213-273-5453
Adresse
12611 HIDDENCREEK WAY, CERRITOS
Compare LIMN vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LIMN
Liminatus Pharma Inc
|
0.1878 | 8.40M | 0 | -9.88M | -9.98M | -0.3644 |
VRTX
Vertex Pharmaceuticals Inc
|
430.44 | 110.81B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
649.76 | 66.02B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
804.25 | 48.27B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.48 | 38.22B | 4.29B | 577.22M | 641.34M | 4.2086 |
ONC
Beone Medicines Ltd Adr
|
308.74 | 30.41B | 5.76B | 514.49M | 1.10B | 4.4813 |
Liminatus Pharma Inc Aktie (LIMN) Neueste Nachrichten
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Liminatus Pharma to Acquire InnocsAI in Stock Deal, 1.6B Shares at $0.20 Plus CVRs - TradingView
LIMN Should I Buy - Intellectia AI
Liminatus Pharma 1Q 2026: Net loss $1.12M, Diluted EPS $(0.03) — 10-Q Summary - TradingView
Liminatus Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Liminatus Pharma (NASDAQ: LIMN) Q1 loss, going concern and Nasdaq listing risks - Stock Titan
TradingKey - TradingKey
Why Liminatus (LIMNW) is still under the radar (+33.11%) 2026-05-11Sector Leader - newser.com
The key risks discussed in Liminatus Pharma (LIMN) earnings | LIMN QX Earnings: Liminatus Pharma Reports No Revenue, Pipeline FocusHigh Attention Stocks - newser.com
LIMN QX Earnings: Liminatus Pharma Reports No Revenue, Pipeline FocusMacro Risk - newser.com
What Liminatus (LIMNW) disclosed about workforce costs | LIMNW: Liminatus Warrants Report No Earnings DataLiquidity Risk - newser.com
Net current asset value per share of Liminatus Pharma, Inc. – NASDAQ:LIMN - TradingView
LIMNW Price History for Liminatus Pharma Warrants Stock - Barchart.com
Liminatus Pharma Stock Surges to Record High After Regaining Nasdaq Compliance - MSN
Is Liminatus (LIMNW) stock trending down today | Liminatus Posts No Financials, Pipeline Drives Warrant MovesHigh Growth - newser.com
Is Liminatus Pharma (LIMN) stock worth buying today Earnings ReportPricing Power - Xã Châu Thành
LIMNW (Liminatus Pharma) Cyclically Adjusted Price-to-FCF : (As of Apr. 22, 2026) - GuruFocus
LIMNW (Liminatus Pharma) PB Ratio : (As of Apr. 21, 2026) - GuruFocus
LIMNW (Liminatus Pharma) Cyclically Adjusted PB Ratio : (As of Apr. 21, 2026) - GuruFocus
Is Liminatus Pharma (LIMN) stock forming lower lows (Institutional Selling) 2026-04-20Social Flow Trades - Cổng thông tin điện tử tỉnh Lào Cai
Liminatus Pharma (LIMN) Stock: Is It Overvalued vs Peers (Bearish Sentiment) 2026-04-18Reward Analysis - Xã Thanh Hà
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market SessionAcurx Pharmaceuticals (NASDAQ:ACXP), Ali - Benzinga
Quarterly Recap: What is the cash position of Liminatus Pharma Inc2026 Trade Ideas & Free Reliable Trade Execution Plans - baoquankhu1.vn
Earnings Report: Is Liminatus Pharma Inc Equity Warrant stock undervalued right nowTrade Volume Report & Verified Stock Trade Ideas - baoquankhu1.vn
Resistance Check: Can INNOVATE Corp stock outperform in a bear marketEarnings Growth Report & High Accuracy Swing Entry Alerts - baoquankhu1.vn
What is the sentiment around Liminatus Pharma (LIMN) Stock | Price at $0.18, Down 1.13%Hot Stocks - newser.com
Quarterly Earnings: Can NRDS be recession proofGlobal Markets & Fast Exit and Entry Trade Guides - baoquankhu1.vn
Update Recap: Will SOBR outperform during market rallies2026 Performance Recap & Reliable Breakout Forecasts - baoquankhu1.vn
Breakout Move: Can Liminatus Pharma Inc Equity Warrant reach resistance levels soonFed Meeting & Weekly Top Performers Watchlists - baoquankhu1.vn
LIMN Rebounds Close to Support Level, Yet Downward Trend Remains Firm - Bitget
Is Liminatus Pharma (LIMN) Stock a Safe Investment | Price at $0.19, Up 6.29%Smart Money Flow - newser.com
Growth Value: Is Liminatus Pharma Inc forming a breakout pattern2026 Patterns & Entry Point Strategy Guides - baoquankhu1.vn
Retail Trends: Whats the fair value of Liminatus Pharma Inc Equity Warrant stock2026 Intraday Action & Weekly Sector Rotation Insights - baoquankhu1.vn
Liminatus Pharma 2025 Annual Report: Pre-Clinical Cancer Therapy Pipeline, Strategy, and Risk Overview - Minichart
Liminatus Pharma 2025 10-K — $0 Revenue, Net Loss $10.21M - TradingView — Track All Markets
Liminatus Pharma (NASDAQ: LIMN) faces cash strain, dilution and Nasdaq listing risks - Stock Titan
Liminatus Pharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Insider Trends: Is Liminatus Pharma Inc stock a smart retirement pick2026 PreEarnings & Weekly Return Optimization Plans - baoquankhu1.vn
FOMO Trade: Is Liminatus Pharma Inc a good ESG investment2026 Momentum & Capital Efficient Trading Techniques - baoquankhu1.vn
Institution Moves: Is Liminatus Pharma Inc stock a top performer YTD2026 Buyback Activity & Stepwise Trade Execution Plans - baoquankhu1.vn
Liminatus Pharma, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Jobs Data: What are the future prospects of Liminatus Pharma Inc Equity WarrantTrade Analysis Report & AI Driven Price Predictions - baoquankhu1.vn
Fundamentals Check: Is Liminatus Pharma Inc Equity Warrant subject to activist investor interest2026 Breakouts & Daily Profit Focused Stock Screening - baoquankhu1.vn
Moving Averages: What are Liminatus Pharma Incs recent SEC filings showingJobs Report & Verified Momentum Stock Alerts - baoquankhu1.vn
LIMN Stock Price, Quote & Chart | LIMINATUS PHARMA INC-CL A (NASDAQ:LIMN) - ChartMill
Weekly Earnings: Is Liminatus Pharma Inc Equity Warrant stock undervalued right nowMarket Activity Summary & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
Aug Patterns: Can BPMC maintain its current growth rate2026 Fundamental Recap & Accurate Technical Buy Alerts - baoquankhu1.vn
Liminatus eyes clinic with CD47-blockade antibody IBA-101 - BioWorld MedTech
Liminatus Pharma to initiate Phase 1 clinical trial for IBA101 antibody - TipRanks
Liminatus Pharma’s IBA101 May Represent the CD47 Innovation Addressing Anemia and Thrombocytopenia in Advanced Immuno-Oncology - Bitget
Finanzdaten der Liminatus Pharma Inc-Aktie (LIMN)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.93%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):